NO20063413L - Nye CC-kjemokinlindrende proteiner - Google Patents

Nye CC-kjemokinlindrende proteiner

Info

Publication number
NO20063413L
NO20063413L NO20063413A NO20063413A NO20063413L NO 20063413 L NO20063413 L NO 20063413L NO 20063413 A NO20063413 A NO 20063413A NO 20063413 A NO20063413 A NO 20063413A NO 20063413 L NO20063413 L NO 20063413L
Authority
NO
Norway
Prior art keywords
chemokine
new
relieving
proteins
senguineus
Prior art date
Application number
NO20063413A
Other languages
English (en)
Inventor
Amanda Proudfoot
Christine Power
Achim Frauenschub
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20063413L publication Critical patent/NO20063413L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Et nytt CC-kjemokinbindende protein er isolert fra spyttet hos Rhipicephalus senguineus. Forbindelser fremstilt i overensstemmelse med foreliggende oppfinnelse kan brukes som anti-inflammatoriske forbindelser og ved behandling eller forebygging av CC-kjemokinrelaterte sykdommer.
NO20063413A 2003-12-24 2006-07-24 Nye CC-kjemokinlindrende proteiner NO20063413L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104973 2003-12-24
PCT/EP2004/053638 WO2005063812A2 (en) 2003-12-24 2004-12-21 Cc-chemokine-binding tick proteins

Publications (1)

Publication Number Publication Date
NO20063413L true NO20063413L (no) 2006-09-25

Family

ID=34717258

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063413A NO20063413L (no) 2003-12-24 2006-07-24 Nye CC-kjemokinlindrende proteiner

Country Status (11)

Country Link
US (1) US7393660B2 (no)
EP (1) EP1697404B1 (no)
JP (1) JP4809242B2 (no)
AT (1) ATE437179T1 (no)
AU (1) AU2004309111B2 (no)
CA (1) CA2544334A1 (no)
DE (1) DE602004022191D1 (no)
ES (1) ES2329584T3 (no)
IL (1) IL176327A (no)
NO (1) NO20063413L (no)
WO (1) WO2005063812A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670802B2 (en) 2005-10-31 2010-03-02 Merck Serono Sa CXC-chemokine antagonists isolated from Rhipicephalus sanguineus
GB0522298D0 (en) * 2005-11-01 2005-12-07 Natural Environment Res Agents that bind IgE
EP1984392B1 (en) * 2006-02-16 2012-08-08 Merck Serono SA Novel cc-chemokine antagonists
WO2007148317A1 (en) * 2006-06-21 2007-12-27 Compugen Ltd. Mcp-1 splice variants and methods of using same
US20100105571A1 (en) 2007-03-27 2010-04-29 Carl Arne Krister Borrebaeck Protein Signature/Markers for the Detection of Adenocarcinoma
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849536A (en) * 1990-03-02 1998-12-15 Bio-Technology General Corp. Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same
WO2000027873A2 (en) * 1998-11-06 2000-05-18 Research Corporation Technologies, Inc. Interleukin-2 binding protein from arthropods
AU2001232052A1 (en) * 2000-02-11 2001-08-20 Evolutec Limited Cytokine inhibitory molecules from tick salivary glands
AU2001255378A1 (en) * 2000-04-14 2001-10-30 The Regents Of The University Of California Inhibition of transmission of tick-borne infections

Also Published As

Publication number Publication date
WO2005063812A2 (en) 2005-07-14
IL176327A (en) 2012-03-29
WO2005063812A3 (en) 2005-10-27
EP1697404B1 (en) 2009-07-22
DE602004022191D1 (de) 2009-09-03
ATE437179T1 (de) 2009-08-15
JP4809242B2 (ja) 2011-11-09
CA2544334A1 (en) 2005-07-14
ES2329584T3 (es) 2009-11-27
AU2004309111B2 (en) 2011-02-24
US20070224125A1 (en) 2007-09-27
JP2008505604A (ja) 2008-02-28
AU2004309111A1 (en) 2005-07-14
IL176327A0 (en) 2006-10-05
EP1697404A2 (en) 2006-09-06
US7393660B2 (en) 2008-07-01

Similar Documents

Publication Publication Date Title
SE9800836D0 (sv) New Compounds
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
NO20063413L (no) Nye CC-kjemokinlindrende proteiner
CL2003002353A1 (es) Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
DK1680507T3 (da) Bakterieekspression af proteaseinhibitorer og varianter deraf
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20056073L (no) Sammensetninger og fremgangsmater til behandling av alvorlig akutt respitatorisk syndrom (SARS)
NO20065536L (no) Behandling av astma hos barn
CY1113651T1 (el) Αντιφλεγμονωδη σκευασματα
WO2005112915A3 (en) Decrease in oxidative stress status through the administration of natural products and pharmaceutical drugs
NO20063842L (no) Silinanforbindelser som cysteinproteaseinhibitorer
SE0302304D0 (sv) Novel compounds
CA3156547A1 (en) COMPOUND HAVING A BRD4 INHIBITOR ACTIVITY, METHOD FOR PREPARING IT AND ITS USE
NO20042861L (no) N-(3-butyn-1-yl)-N-hydroksyurea
DK1492773T3 (da) 4-(Heterocyclyl)-benzensulfoximin-forbindelser til behandling af inflammation
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
GB0003025D0 (en) Novel compounds
WO2002068476A3 (en) Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
DK1095059T3 (da) Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse
WO2003093419A3 (en) Preventing secondary lymphedema with vegf-d dna
WO2006047162A3 (en) Compositions and methods for treatment of disease caused by yersinia spp infection

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application